+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Clinical Trial Supplies Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924676
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The clinical trial supplies market is evolving rapidly due to increasing operational complexity, regulatory scrutiny, and the shift toward decentralized and technology-enabled trial models. Senior executives face new imperatives to safeguard trial integrity through optimized supply chain strategies and effective risk management.

Market Snapshot: Clinical Trial Supplies Market Growth

The clinical trial supplies market expanded from USD 3.96 billion in 2025 to USD 4.31 billion in 2026, with projections reaching USD 7.28 billion by 2032. The sector is achieving a CAGR of 9.09%, reflecting robust sectoral momentum. Increased complexity in research protocols, evolving approaches to supply management, and heightened oversight from regulatory bodies are all fueling demand. As clinical trials diversify across global regions, requirements for agility and transparency have intensified, compelling organizations to modernize supply frameworks.

Scope & Segmentation: Comprehensive Sector Overview

  • Product Types: Ancillaries, Frozen Supplies, Refrigerated Supplies, and Room Temperature Supplies. Distinct categories mandate specialized handling, consistent monitoring, and tailored transport protocols based on product characteristics.
  • Clinical Trial Phases: Encompasses Phase I to Phase IV, where operational priorities change as scalability, flexibility, and documentation become increasingly critical with trial maturation.
  • Therapeutic Indications: Focus on Cardiovascular, Central Nervous System, Infectious Diseases, and Oncology trials, all presenting distinctive dosing, logistics, and cold-chain challenges.
  • Packaging Formats: Ampoules, Bottles, Cartridges, Pre-Filled Syringes, and Vials. Each format influences sterility, user safety, and shipping protocols.
  • Distribution Channels: Direct Shipment, In-House Logistics (both cold chain and standard logistics), and Third Party Logistics groups, which manage variable risk profiles and regulatory touchpoints.
  • Trial Types: Interventional and Observational studies, shaping site-level needs, data management flows, and return logistics planning.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific. Each geography is influenced by specific regulatory requirements, logistical infrastructure, and local supply partnerships.
  • Technologies: Digital sensors, blockchain documentation, real-time monitoring, and modular vendor management systems enhance supply chain transparency and support risk mitigation measures at every stage.

Key Takeaways: Strategic and Operational Insights

  • Resilient clinical trial supply chains integrate advanced technologies with changing compliance norms and orchestrated logistics coordination for operational continuity.
  • Interoperability standards are pivotal in managing new packaging solutions and real-time environmental tracking, ensuring reliable cold-chain performance across multiple stakeholders.
  • Proactive compliance efforts, such as early implementation of control checkpoints and collaborative practices between operational, procurement, and quality assurance teams, strengthen overall process integrity.
  • Decentralization and direct-to-patient delivery models require fulfillment approaches that balance flexibility, oversight, and reach, while maintaining stringent product control.
  • Modular inventory positioning, vendor performance tracking, and scenario planning enable organizations to anticipate operational disruptions and uphold participant safety.

Tariff Impact: Navigating Shifts in Sourcing and Logistics

New tariff measures in 2025 have heightened cross-border regulatory requirements and operational demands for U.S.-based clinical trials. Increased duties are causing sponsors to review supplier locations, develop dual-sourcing for vital materials, and recalibrate inventory strategies. Bonded storage solutions can help maintain supply continuity but demand close oversight to avoid compliance and shelf-life challenges. Advanced customs planning and early engagement with trade specialists support timely responses to regulatory change and cost uncertainty.

Methodology & Data Sources

This analysis adopts a mixed-methods approach, incorporating interviews with supply chain, procurement, and logistics experts, as well as rigorous regulatory reviews and secondary research. Input from industry practitioners and regulatory authorities ensures each finding and recommendation is technically validated and aligned with market realities.

Why This Report Matters

  • Equips senior leaders to benchmark and fortify operational resilience, sustaining reliable clinical supply under intensifying market and regulatory conditions.
  • Offers actionable segmentation, compliance, and technology adoption insights to refine risk management and procurement decisions.
  • Aligns executive attention on cross-functional collaboration to maximize trial supply performance, reduce disruptions, and preserve patient safety standards.

Conclusion

Successful clinical trial supply strategies demand integrated planning, targeted technology use, and dynamic vendor management. Leadership focus on agile execution is essential for continuity and compliance amid evolving trial environments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Clinical Trial Supplies Market, by Product Type
8.1. Ancillaries
8.2. Frozen Supplies
8.3. Refrigerated Supplies
8.4. Room Temperature Supplies
9. Clinical Trial Supplies Market, by Phase
9.1. Phase I
9.2. Phase II
9.3. Phase III
9.4. Phase IV
10. Clinical Trial Supplies Market, by Indication
10.1. Cardiovascular
10.2. Central Nervous System
10.3. Infectious Diseases
10.4. Oncology
11. Clinical Trial Supplies Market, by Packaging Type
11.1. Ampoules
11.2. Bottles
11.3. Cartridges
11.4. Pre-Filled Syringes
11.5. Vials
12. Clinical Trial Supplies Market, by Trial Type
12.1. Interventional
12.2. Observational
13. Clinical Trial Supplies Market, by Distribution Channel
13.1. Direct Shipment
13.2. In-House Logistics
13.2.1. Cold Chain Management
13.2.2. Standard Logistics
13.3. Third Party Logistics
13.3.1. Non-Temperature-Controlled Logistics
13.3.2. Temperature-Controlled Logistics
14. Clinical Trial Supplies Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Clinical Trial Supplies Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Clinical Trial Supplies Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Clinical Trial Supplies Market
18. China Clinical Trial Supplies Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Almac Group
19.6. Ancillare, LP
19.7. Biocair
19.8. Catalent, Inc.
19.9. Clinigen Group
19.10. Eurofins Scientific, Inc.
19.11. Infosys Limited
19.12. KLIFO A/S
19.13. Liveo Research GmbH
19.14. Lonza Group
19.15. Marken
19.16. Myonex, Inc.
19.17. N-SIDE
19.18. Parexel International
19.19. PCI Pharma Services
19.20. Piramal Pharma Solutions
19.21. PRA Health Sciences
19.22. SIRO Clinpharm Pvt. Ltd.
19.23. Thermo Fisher Scientific
19.24. UDG Healthcare plc
List of Figures
FIGURE 1. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ANCILLARIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ANCILLARIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ANCILLARIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY FROZEN SUPPLIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY FROZEN SUPPLIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY FROZEN SUPPLIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REFRIGERATED SUPPLIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REFRIGERATED SUPPLIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REFRIGERATED SUPPLIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ROOM TEMPERATURE SUPPLIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ROOM TEMPERATURE SUPPLIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ROOM TEMPERATURE SUPPLIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AMPOULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BOTTLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY VIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY VIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY OBSERVATIONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY OBSERVATIONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY OBSERVATIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DIRECT SHIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DIRECT SHIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DIRECT SHIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COLD CHAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COLD CHAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COLD CHAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STANDARD LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STANDARD LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STANDARD LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NON-TEMPERATURE-CONTROLLED LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NON-TEMPERATURE-CONTROLLED LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NON-TEMPERATURE-CONTROLLED LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TEMPERATURE-CONTROLLED LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TEMPERATURE-CONTROLLED LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TEMPERATURE-CONTROLLED LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 125. EUROPE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. EUROPE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 128. EUROPE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 129. EUROPE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 130. EUROPE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. EUROPE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 143. AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 146. AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 147. AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 148. AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 149. AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 151. AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. ASEAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 165. ASEAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 166. ASEAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 167. ASEAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 168. ASEAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. ASEAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 170. ASEAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 171. GCC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GCC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. GCC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 174. GCC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 175. GCC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 176. GCC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 177. GCC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. GCC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 179. GCC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 189. BRICS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. BRICS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. BRICS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 192. BRICS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 193. BRICS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 194. BRICS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 195. BRICS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. BRICS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 197. BRICS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 198. G7 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. G7 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. G7 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 201. G7 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 202. G7 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 203. G7 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 204. G7 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 205. G7 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 206. G7 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 207. NATO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. NATO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 209. NATO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 210. NATO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 211. NATO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 212. NATO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 213. NATO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 214. NATO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 215. NATO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
TABLE 226. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
TABLE 229. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 230. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 231. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2032 (USD MILLION)
TABLE 232. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 233. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2032 (USD MILLION)
TABLE 234. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Clinical Trial Supplies market report include:
  • Almac Group
  • Ancillare, LP
  • Biocair
  • Catalent, Inc.
  • Clinigen Group
  • Eurofins Scientific, Inc.
  • Infosys Limited
  • KLIFO A/S
  • Liveo Research GmbH
  • Lonza Group
  • Marken
  • Myonex, Inc.
  • N-SIDE
  • Parexel International
  • PCI Pharma Services
  • Piramal Pharma Solutions
  • PRA Health Sciences
  • SIRO Clinpharm Pvt. Ltd.
  • Thermo Fisher Scientific
  • UDG Healthcare plc

Table Information